Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/7956017

Download in:

View as

General Info

PMID
7956017